Kris Kaemingk
Overview
Explore the profile of Kris Kaemingk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stenzel S, Krull K, Hockenberry M, Jain N, Kaemingk K, Miketova P, et al.
J Pediatr Hematol Oncol
. 2010 Jan;
32(2):113-8.
PMID: 20098337
Neurobehavioral problems after chemotherapy treatment for pediatric acute lymphoblastic leukemia (ALL) have been a recent focus of investigation. This study extended previous research that suggested oxidative stress as a potential...
2.
Caron J, Krull K, Hockenberry M, Jain N, Kaemingk K, Moore I
Pediatr Blood Cancer
. 2009 Jun;
53(4):551-6.
PMID: 19499584
Background: Neurocognitive sequelae following treatment for pediatric acute lymphoblastic leukemia (ALL) has been reported in a significant proportion of survivors, including those treated only with chemotherapy. Early identification of children...
3.
Moore I, Miketova P, Hockenberry M, Krull K, Pasvogel A, Carey M, et al.
Biol Res Nurs
. 2008 Apr;
9(4):311-9.
PMID: 18398226
Treatment advances, including central nervous system (CNS) treatment with methotrexate, have led to significant gains in disease-free survival from childhood acute lymphoblastic leukemia (ALL). However, methotrexate has been associated with...
4.
Hockenberry M, Krull K, Moore K, Gregurich M, Casey M, Kaemingk K
J Pediatr Hematol Oncol
. 2007 Sep;
29(8):535-9.
PMID: 17762494
Background: Improved survival for children with acute lymphocytic leukemia (ALL) has allowed investigators to focus on the adverse or side effects of treatment and to develop interventions that promote cure...
5.
Miketova P, Kaemingk K, Hockenberry M, Pasvogel A, Hutter J, Krull K, et al.
Biol Res Nurs
. 2004 Dec;
6(3):187-95.
PMID: 15583359
Central nervous system (CNS) treatment contributes to improved long-term disease-free survival from childhood acute lymphoblastic leukemia (ALL) by significantly decreasing the rate of disease relapse. Methotrexate (MTX), a drug commonly...
6.
Moore I, Challinor J, Pasvogel A, Matthay K, Hutter J, Kaemingk K
Oncol Nurs Forum
. 2003 Sep;
30(5):E84-91.
PMID: 12949601
Purpose/objectives: To describe behavioral adjustment in children and adolescents with acute lymphoblastic leukemia (ALL) and to determine whether behavioral adjustment is correlated with cognitive and academic abilities. Design: Descriptive, cross-sectional...